Electra Therapeutics ETRA
NASDAQ ETRA
$9.45 +1.46 (+18.27%)
At close: Nov 11, 2026 · 4:00 PM EST

Electra Therapeutics (ETRA) Ending Cash Balance (2024 - 2026)

Analysis

Electra Therapeutics (ETRA) Ending Cash Balance (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 16.91 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 7.94 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.88 Bn
10 Electra Therapeutics 234.34 Mn 136.61 Mn - 66.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 66.51 Mn
Dec 31, 2025 33.01 Mn
Dec 31, 2024 14.79 Mn
API Access

Electra Therapeutics Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=ETRA&period=max&api_key=YOUR_API_KEY